Thermo Fisher Scientific Launches CE-IVD-Marked Next-Generation TaqPath COVID-19 2.0 Test

Thermo Fisher Scientific Launches CE-IVD-Marked Next-Generation TaqPath COVID-19 2.0 Test Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations INCHINNAN, Scotland, June 22, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new CE-IVD-marked COVID-19 test. The TaqPath COVID-19... Read more

Novel 4D-Metabolomics and 4D-Lipidomics Workflows, Libraries and ML-based CCS Prediction Tools to Transform Metabolomics and Lipidomics

New VIP-HESI ion source boosts sensitivity in analytical flow 4D-Metabolomics, 4D-Lipidomics and small molecule quantitative screening workflows by more than 10x Introducing new METLIN-4D large 4D-Metabolomics CCS library for timsTOF platform Integration of machine integration for CCS-Predict Pro software for unknown metabolites New CCS-enabled 4D workflows in MetaboScape and TASQ 2022 software, including 4D-Lipidomics tools... Read more

Danaher To Acquire Aldevron

WASHINGTON, June 17, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance of commercial paper. Founded in 1998... Read more

Bruker Updates FY 2021 Guidance and Provides Medium Term Outlook at Virtual Investor Day

BILLERICA, Mass.–(BUSINESS WIRE)– At its 2021 Virtual Investor Day today, Bruker Corporation (Nasdaq: BRKR) will discuss the Company’s strategy and Project Accelerate 2.0 initiatives, including the Company’s potential high-growth opportunities in the areas of proteomics and spatial biology. Bruker will also update its fiscal year 2021 guidance and will discuss its medium term financial outlook... Read more

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology CARLSBAD, Calif., June 16, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. This grant aims to provide funding for high-quality molecular... Read more

Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021

Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021 Enhanced solution delivers balance of speed and quality to accelerate and expedite DNA to Investigational New Drug in as little as 13 months WALTHAM, Mass., June 14, 2021 /PRNewswire/ — BIO DIGITAL 2021 – New... Read more

Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021 WALTHAM, Mass., June 8, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual... Read more

JEOL and SCiLS Sign a Distribution Agreement for SCiLS Lab MVS Software

JEOL Ltd. and SCiLS, a division of Bruker Daltonics, announced that they have concluded a non-exclusive, worldwide distribution agreement for SCiLS Lab MVS software. The SCiLS Lab has been the software of choice for researchers wanting to gain new insights from mass spectrometry imaging. Used in science and industry, the software sets new standards in... Read more